» Articles » PMID: 22387060

Associations Between Serum Lipoprotein(a) Levels and the Severity of Coronary and Aortic Atherosclerosis

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2012 Mar 6
PMID 22387060
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate the associations between Lp(a) levels and coronary and aortic atherosclerosis, we performed aortic MRI in 143 patients undergoing coronary angiography. Severity of aortic atherosclerosis was represented as plaque scores. Of the 143 patients, 104 had coronary artery disease (CAD). Thoracic and abdominal aortic plaques were found in 89 and 131 patients. Lp(a) levels increased stepwise with the number of stenotic coronary vessels: 15.7 (CAD(-)), 21.2 (1-vessel), 21.4 (2-vessel), and 22.9 mg/dl (3-vessel) (P<0.05). For aortic atherosclerosis, 143 patients were divided into quartiles by plaque scores. Lp(a) did not differ among quartiles of thoracic plaques: 17.1, 19.0, 23.5, and 21.2 mg/dl (P=NS), whereas Lp(a) increased stepwise with quartiles of abdominal plaques: 17.1, 19.2, 19.1, and 24.0 mg/dl (P<0.05). Lp(a) was an independent factor for CAD and abdominal aortic plaques, but not thoracic plaques. Thus, Lp(a) levels were associated with aortic atherosclerosis, especially in abdominal aorta, as well as coronary atherosclerosis.

Citing Articles

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.

Makover M, Shapiro M, Toth P Am J Prev Cardiol. 2022; 12:100371.

PMID: 36124049 PMC: 9482082. DOI: 10.1016/j.ajpc.2022.100371.


Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.

Obisesan O, Kou M, Wang F, Boakye E, Honda Y, Uddin S J Am Heart Assoc. 2022; 11(11):e024870.

PMID: 35656990 PMC: 9238743. DOI: 10.1161/JAHA.121.024870.


Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes.

Tang Y, Li S, Hu J, Sun K, Liu L, Xu D Cardiovasc Diabetol. 2020; 19(1):33.

PMID: 32169071 PMC: 7071562. DOI: 10.1186/s12933-020-01009-4.


Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein(a).

John J, Kalaivani V, Geetha M, Appukuttan P Exp Biol Med (Maywood). 2019; 244(11):893-900.

PMID: 31397607 PMC: 6690144. DOI: 10.1177/1535370219855002.


Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease.

Ma K, Gong T, Hu Z, Zhang Y, Wang G, Liu L BMC Nephrol. 2018; 19(1):192.

PMID: 30071823 PMC: 6090984. DOI: 10.1186/s12882-018-0986-2.